AlphaMadera's AlphaVal page computes Victoria's Secret & Co.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag VSCO as undervalued, fairly valued, or overvalued.

What is Victoria's Secret & Co.'s fair value?

Fair value for VSCO is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value VSCO?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from VSCO's most recent reported fundamentals.

VSCO - Victoria's Secret & Co.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $57.67 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 40% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Moderate

Trading 37.8% above fair value

Current Price $52.45

Bear Case $30.45 41.9% downside ($30.45 - $52.45) / $52.45 = -41.9% $2.21 × 12x P/E

Fair Value $38.07 27.4% downside ($38.07 - $52.45) / $52.45 = -27.4% $2.21 × 15x P/E

Bull Case $45.68 12.9% downside ($45.68 - $52.45) / $52.45 = -12.9% $2.21 × 18x P/E

Adjust Assumptions

P/E Multiple

15.0x

Adjusted EPS

2.21$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 23.7x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $57.67 from 14 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $38.07 per share.

Warnings

ℹ Wall Street's average price target is $57.67 (from 14 analysts). Our estimate is 42% below the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples